Linning Yu
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Drug-Induced Hepatotoxicity and Protection 2
- Piperaceae Chemical and Biological Studies 1
-
- Bioactive Compounds and Antitumor Agents 4
- Co-authors
- Judy L. Bolton (7 shared papers)Abdul E. Mutlib (5 shared papers)Anis Ahmed Khan (2 shared papers)Richard Bruce van Breemen (4 shared papers)Rasmy E. Talaat (3 shared papers)Joseph A. Ware (2 shared papers)Joe Palandra (2 shared papers)Timothy G. Brayman (2 shared papers)
- Journals
- Chemical Research in Toxicology (9 papers)Mutation research. Fundamental and molecular mechanisms of mutagenesis (1 paper)Molecular Pharmaceutics (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)The FASEB Journal (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Linning Yu
15 papers receiving 628 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 255
- Toxicology 70
- Oncology 123
- Analytical Chemistry 48
- Spectroscopy 46
Countries citing papers authored by Linning Yu
This map shows the geographic impact of Linning Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linning Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linning Yu more than expected).
Fields of papers citing papers by Linning Yu
This network shows the impact of papers produced by Linning Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linning Yu. The network helps show where Linning Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linning Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 137 | |
| 2 | 2008 | 85 | |
| 3 | 2008 | 75 | |
| 4 | 2004 | 70 | |
| 5 | 2003 | 56 | |
| 6 | 2010 | 55 | |
| 7 | 2007 | 45 | |
| 8 | 2001 | 34 | |
| 9 | 2009 | 27 | |
| 10 | 2004 | 24 | |
| 11 | 2004 | 21 | |
| 12 | 2003 | 18 | |
| 13 | 2004 | 14 | |
| 14 | 2007 | 8 | |
| 15 | 2006 | 3 |
About Linning Yu
Linning Yu is a scholar working on Pharmacology, Toxicology, Cancer Research, Oncology and Molecular Biology, having authored 15 papers that have together received 672 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Piperaceae Chemical and Biological Studies (1 paper). The work is most often cited by research in Pharmacology (255 citations), Toxicology (70 citations), Oncology (123 citations), Analytical Chemistry (48 citations) and Spectroscopy (46 citations). Linning Yu has collaborated with scholars based in United States and Canada. Frequent co-authors include Judy L. Bolton, Abdul E. Mutlib, Anis Ahmed Khan, Richard Bruce van Breemen, Rasmy E. Talaat, Joseph A. Ware, Joe Palandra, Timothy G. Brayman, Robert J. Espina and JoAnn Scatina. Their work appears in journals such as Chemical Research in Toxicology, Mutation research. Fundamental and molecular mechanisms of mutagenesis, Molecular Pharmaceutics, Methods in enzymology on CD-ROM/Methods in enzymology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.